Non-small cell lung cancer
Conditions
Interventions
Control Group:Chemotherapy + conventional therapy
Treatment group:Chemotherapy + Conventional therapy + Heat-sensitive moxibustion
Sponsors
Guangdong Provincial Hospital of Integrated Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Pathological diagnosis: non-small cell lung cancer; clinical stage: IIIb-IV; no surgical options available for primary lung cancer patients; Chinese medicine syndrome type: qi deficiency with phlegm and blood stasis. (2) Patient age: 18-85 years old, regardless of sex. (3) Karnofsky Performance Status =60; able to tolerate chemotherapy; expected survival =3 months. (4) Not participating in other clinical trials; no prior anti-tumor therapy. (5) Patient is mentally alert; cooperative; articulate; able to communicate effectively. (6) Willing to participate in the study; able to sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Exclude patients with recurrence, metastasis, or secondary lung cancer after treatment. (2) Exclude patients with other malignant tumors, bone metastasis, or immune-related diseases. (3) Exclude patients with severe hepatic or renal dysfunction and severe cardiovascular diseases. (4) Exclude patients with mental disorders or cognitive impairments. (5) Exclude patients with incomplete clinical data or inability to complete questionnaire items.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (Version 3.0);Chinese medicine syndrome scale;Natural killer cell level;T lymphocyte subset levels;the level of programmed cell death protein-1; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Blood Count;Liver Function Tests;Renal Function Tests; | — |
Countries
China
Contacts
Public ContactTian Ning
Guangdong Provincial Hospital of Integrated Chinese and Western Medicine
Outcome results
None listed